|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 116.36 EUR | +0.52% |
|
+2.61% | +9.65% |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
| 08-05 | Gilead Sciences Delivers 'Plenty' to Like in Q2, RBC Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,098B | |||||
| 631B | - | - | - | ||
| 438B | |||||
| 368B | |||||
| 298B |
Select your edition
All financial news and data tailored to specific country editions
